Mable (Neurolytic Healthcare)
Health Care, Medical, Neuroscience
Founded in 1/1/19
Oxford, Oxfordshire, United Kingdom
For Profit
About Mable (Neurolytic Healthcare)
Neurolytic Healthcare provides personalized medicine for neurological conditions. Neurolytic Healthcare collects and extracts insights from a combination of genetic and biomarker data to enhance diagnosis and help clinicians decide on optimal treatment strategies for neurological conditions. The company delivers digitally and genomically-driven medical devices to improve the current treatment of migraine and other neurological disorders, including a diagnostic support tool, pharmacogenetic test, and a mobile app for migraine event prediction.
Company Metrics
- Employees: 11-50
- Monthly Visits: None
- Tech Stack: None active products
Financial Information
- Estimated Revenue:
- Total Funding: 3250000 USD
- Last Funding: 3200000 USD (Seed)
- Funding Status: Seed
Technology Stack
Mable (Neurolytic Healthcare) actively uses None products in their tech stack.
Market Presence
Industries: Health Care, Medical, Neuroscience
Headquarters: Oxford, Oxfordshire, United Kingdom
Leadership
- Roman Rothaermel - Co-Founder & CEO at mable | Neurolytic Healthcare LinkedIn